University of Sydney
222
45
62
95
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
4.5%
10 terminated/withdrawn out of 222 trials
90.5%
+4.0% vs industry average
16%
36 trials in Phase 3/4
8%
8 of 95 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (222)
RegoNivo vs Standard of Care Chemotherapy in AGOC
Role: collaborator
30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants
Role: collaborator
Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging
Role: lead
Post-Operative Prediction of PulmonarY Function
Role: lead
PRIORITY-CONNECT 2 Trial
Role: collaborator
A Master Trial Assessing the Technical Feasibility of First-In-Human Real-Time Image Guided Radiation Therapy Methods
Role: lead
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
Role: lead
MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy
Role: lead
Ventilation Using Radiographic Examination: Functional Lung Imaging Techniques for the Reduction of Toxicity in Functional Avoidance Radiation Therapy
Role: lead
Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring
Role: lead
Respiratory Adaptive Computed Tomography: Feasibility Study on Real-Time Gated 4DCT for Lung Cancer Radiotherapy
Role: lead
Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy
Role: lead
Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)
Role: lead
Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
Role: lead
Collection of Head Images During Radiotherapy
Role: lead
Nano-X Image Guidance: CBCT With Gravity-induced Motion
Role: lead
Patient Experience and Acceptance of Horizontal Rotation
Role: lead
eCardiacRehab - a Hybrid Patient-Centered eHealth Programme
Role: collaborator
THRIVE - Trial of Passive Humoral RSV Immunity for Value and Effectiveness
Role: collaborator
Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis
Role: collaborator